These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 17475706

  • 1. Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy.
    Tatar O, Adam A, Shinoda K, Eckert T, Scharioth GB, Klein M, Yoeruek E, Bartz-Schmidt KU, Grisanti S.
    Br J Ophthalmol; 2007 Sep; 91(9):1183-9. PubMed ID: 17475706
    [Abstract] [Full Text] [Related]

  • 2. Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes.
    Tatar O, Shinoda K, Adam A, Eckert T, Eckardt C, Lucke K, Deuter C, Bartz-Schmidt KU, Grisanti S.
    Br J Ophthalmol; 2007 Feb; 91(2):166-73. PubMed ID: 16987895
    [Abstract] [Full Text] [Related]

  • 3. Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization.
    Tatar O, Shinoda K, Kaiserling E, Pertile G, Eckardt C, Mohr A, Yoeruek E, Szurman P, Bartz-Schmidt KU, Grisanti S.
    Arch Ophthalmol; 2008 Feb; 126(2):193-9. PubMed ID: 18268209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy.
    Tatar O, Adam A, Shinoda K, Stalmans P, Eckardt C, Lüke M, Bartz-Schmidt KU, Grisanti S.
    Am J Ophthalmol; 2006 Jul; 142(1):95-104. PubMed ID: 16815256
    [Abstract] [Full Text] [Related]

  • 6. Expression of endostatin in human choroidal neovascular membranes secondary to age-related macular degeneration.
    Tatar O, Shinoda K, Adam A, Rohrbach JM, Lucke K, Henke-Fahle S, Bartz-Schmidt KU, Grisanti S.
    Exp Eye Res; 2006 Aug; 83(2):329-38. PubMed ID: 16584730
    [Abstract] [Full Text] [Related]

  • 7. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
    Tatar O, Kaiserling E, Adam A, Gelisken F, Shinoda K, Völker M, Lafaut BA, Bartz-Schmidt KU, Grisanti S.
    Arch Ophthalmol; 2006 Jun; 124(6):815-23. PubMed ID: 16769835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Verteporfin photodynamic therapy induced apoptosis in choroidal neovascular membranes.
    Petermeier K, Tatar O, Inhoffen W, Völker M, Lafaut BA, Henke-Fahle S, Gelisken F, Ziemssen F, Bopp S, Bartz-Schmidt KU, Grisanti S.
    Br J Ophthalmol; 2006 Aug; 90(8):1034-9. PubMed ID: 16613924
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical trial of verteporfin photodynamic therapy in Chinese age-related macular degeneration with subfoveal predominant choroidal neovascularization patients].
    Chen YX, Ge J, Yan M, Jin CJ, Zhang MX, Dong FT, Lu F, Zhang CF, Zhao JL.
    Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):198-205. PubMed ID: 17605900
    [Abstract] [Full Text] [Related]

  • 16. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 19. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM, Michels S.
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.